Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:BMR

Biomed Realty Trust (BMR) Stock Price, News & Analysis

Biomed Realty Trust logo

About Biomed Realty Trust Stock (NYSE:BMR)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$2.13
$2.30
50-Day Range
N/A
52-Week Range
$17.94
$25.08
Volume
110,767 shs
Average Volume
3.29 million shs
Market Capitalization
$28.34 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.

Remove Ads
Receive BMR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biomed Realty Trust and its competitors with MarketBeat's FREE daily newsletter.

BMR Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

BMR Stock Analysis - Frequently Asked Questions

Biomed Realty Trust Inc (NYSE:BMR) posted its quarterly earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 EPS for the quarter, topping analysts' consensus estimates of $0.37 by $0.04. The company's revenue for the quarter was up 5.4% on a year-over-year basis.

Biomed Realty Trust (BMR) raised $8 million in an initial public offering on Tuesday, February 28th 2023. The company issued 1,950,000 shares at a price of $4.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biomed Realty Trust investors own include NVIDIA (NVDA), Tesla (TSLA), Ford Motor (F), Meta Platforms (META), Broadcom (AVGO), Norwegian Cruise Line (NCLH) and NIO (NIO).

Company Calendar

Last Earnings
4/28/2015
Today
4/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Prepackaged software
Sub-Industry
Office REITs
Current Symbol
NYSE:BMR
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.91 million
Price / Cash Flow
N/A
Book Value
$0.80 per share
Price / Book
2.75

Miscellaneous

Free Float
N/A
Market Cap
$28.34 million
Optionable
Not Optionable
Beta
5.22
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NYSE:BMR) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners